Transcripts NeuroPace, Inc.

Equities

NPCE

US6412881053

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
6.55 ^USD	+0.15%		+0.15%	-36.47%

May. 13	Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating	MT
May. 08	NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : NeuroPace, Inc., Q1 2024 Earnings Call, May 08, 2024	May. 08
Transcript : NeuroPace, Inc., Q4 2023 Earnings Call, Mar 05, 2024	Mar. 05
Transcript : NeuroPace, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 07:30 AM	Jan. 11
Transcript : NeuroPace, Inc., Q3 2023 Earnings Call, Nov 06, 2023	Nov. 06
Transcript : NeuroPace, Inc., Q2 2023 Earnings Call, Aug 08, 2023	23-08-08
Transcript : NeuroPace, Inc., Q1 2023 Earnings Call, May 04, 2023	23-05-04
Transcript : NeuroPace, Inc., Q4 2022 Earnings Call, Mar 02, 2023	23-03-02
Transcript : NeuroPace, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-12-2023 09:00 AM	23-01-12
Transcript : NeuroPace, Inc., Q3 2022 Earnings Call, Nov 08, 2022	22-11-08
Transcript : NeuroPace, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 12:20 PM	22-09-13
Transcript : NeuroPace, Inc., Q2 2022 Earnings Call, Aug 11, 2022	22-08-11
NeuroPace, Inc. Provides Earnings Guidance for the Full Year 2022	22-08-11	CI
Transcript : NeuroPace, Inc., Q1 2022 Earnings Call, May 12, 2022	22-05-12
NeuroPace, Inc. Provides Revenue Guidance for the Year 2022	22-05-12	CI
Transcript : NeuroPace, Inc., Q4 2021 Earnings Call, Mar 10, 2022	22-03-10
NeuroPace, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2022	22-03-10	CI
Transcript : NeuroPace, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-12-2022 11:15 AM	22-01-12
NeuroPace, Inc. Announces Preliminary, Unaudited Revenue Guidance for the Fourth Quarter and Full-Year Ended December 31, 2021	22-01-11	CI
Transcript : NeuroPace, Inc., Q3 2021 Earnings Call, Nov 10, 2021	21-11-10
Neuropace, Inc. Provides Revenue Guidance for the Full Year 2021	21-11-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Transcripts NeuroPace, Inc.

Equities

NPCE

US6412881053

Transcripts

Filters